Original Research
N-Acetylcysteine Augmentation for Treatment-Resistant OCD
About half of OCD patients treated with an adequate trial of serotonin reuptake inhibitors (SRIs) fail to fully respond to treatment. This randomized controlled trial examined whether N-acetylcysteine, a...
